GEODE CAPITAL MANAGEMENT, LLC - ASSERTIO THERAPEUTICS INC ownership

ASSERTIO THERAPEUTICS INC's ticker is ASRT and the CUSIP is 04545L107. A total of 1 filers reported holding ASSERTIO THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of ASSERTIO THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$748,000
-70.3%
1,151,783
-42.8%
0.00%
Q4 2019$2,518,000
+129.3%
2,014,406
+134.8%
0.00%
Q3 2019$1,098,000
-63.4%
857,847
-1.2%
0.00%
-100.0%
Q2 2019$2,996,000
-26.0%
868,643
+8.8%
0.00%0.0%
Q1 2019$4,048,000
-17.2%
798,642
-41.0%
0.00%0.0%
Q4 2018$4,886,000
+29.0%
1,353,822
+110.2%
0.00%0.0%
Q3 2018$3,787,000644,0730.00%
Other shareholders
ASSERTIO THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
TSP Capital Management Group, LLC 127,850$164,0000.08%
PERKINS CAPITAL MANAGEMENT INC 69,600$89,0000.08%
GLOBEFLEX CAPITAL L P 213,991$274,0000.06%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 1,500,000$1,920,000,0000.05%
DELTEC ASSET MANAGEMENT LLC 162,700$208,0000.05%
Spark Investment Management LLC 285,588$365,0000.05%
Factorial Partners, LLC 37,000$47,360,0000.04%
HighVista Strategies LLC 43,400$56,0000.04%
OAKTREE CAPITAL MANAGEMENT LP 1,492,455$1,910,0000.04%
OXFORD ASSET MANAGEMENT LLP 1,036,375$1,327,0000.03%
View complete list of ASSERTIO THERAPEUTICS INC shareholders